Primary research interests include the epidemiology and pathogenesis of HIV/AIDS, evaluating the effectiveness of antiretroviral therapy in observational studies, and the effects of HIV infection and treatment on women's reproductive health.

Dr. Golub is Director of the Epidemiology/Biostatistics Core for a NIH-funded program project to study HIV susceptibility and pathogenesis in the female genital tract. She is also co-Principal Investigator of the data management and analysis center for the Women's Interagency HIV Study (WIHS), a nationwide cohort study of HIV-infected and uninfected women, as well as co-investigator for the Center for the Analysis and Management of the Multicenter AIDS Cohort Study (MACS), a nationwide cohort study of HIV-infected and uninfected men.

Epidemiology; HIV; Women; Antiretroviral therapy; Injection drug users; HCV

2009: Awardee, National Institutes of Health Clinical Research Loan Repayment Program (renewal)

2008: Nominee, the Charles C. Shepard Science Award (Garfein RS, Golub ET, …, Thiede H. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS 2007 Sept;21(14):1923-32)

2007: Awardee, National Institutes of Health Clinical Research Loan Repayment Program

2002: NIDA Director’s Travel Award, College on Problems of Drug Dependence 64th Annual Scientific Meeting, Quebec City, Quebec, Canada.

2001: NIDA Director's Travel Award, College on Problems of Drug Dependence 63rd Annual Scientific Meeting, Scottsdale, Arizona.

2001-2003: National Institute on Drug Abuse Institutional NRSA Postdoctoral Fellowship, Johns Hopkins University.

2009 Publications:

----------------------------------

Yin MT, Lu D, Cremers S, Tien PC, Cohen MH, Shi Q, Shane E, Golub ET, Anastos K. Short term bone loss in HIV infected premenopausal women. In Press, JAIDS.

Ganesan A, Benning L, Golub ET, Riddle M, Crum-Cianflone N, Tasker S, Jacobson L, Gange SJ. Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens. In Press, AIDS Research and Therapy.

Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med 2009;49:68-73.

Mansoor A, Golub ET, DeHovitz J, Anastos K, Kaplan RC, Lazar J. The Association of HIV infection with Left Ventricular Mass/Hypertrophy. AIDS Res Hum Retroviruses 2009 May;25(5):475-81.

Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L. Hepatitis C seropositivity and kidney function decline among women with HIV: Data from the Women’s Interagency HIV Study. Am J Kidney Dis 2009; 54(1):43-50.

Walzer PD, Djawe K, Levin L, Daly KR, Koch J, Kingsley L, Witt M, Golub ET, Bream JH, Taiwo B, Morris A. Long-Term Serologic Responses to the Major Surface Glycoprotein in Human Immunodeficiency Virus Subjects With and Without Pneumocystis jirovecii Infection. J Infect Dis 2009 May 1;199(9):1335-44.

2008 Publications:

----------------------------------

Seifer DB, Golub ET, Lambert-Messerlian G, Benning L, Anastos KA, Watts DH, Cohen MH, Karim R, Young MA, Minkoff H, Greenblatt RM. Variations in serum mullerian inhibiting substance between white, black, and Hispanic women. In Press, Fertil Steril 2008.

Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, Plankey MW, Grey DD. Crack cocaine, disease progression, and mortality in a multi-center cohort of HIV-1 positive women. AIDS 2008 Jul 11;22(11):1355-63.

Szczech L, Golub ET, Springer G, Augenbraun M, Young M, Gandhi M, Gillespie BS, Anastos K. Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. J Acquir Immune Defic Syndr 2008 Jul 1;48(3):360-361.

Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA. Effects of a randomized intervention trial to reduce lending of used injection equipment among HCV-infected injection drug users. Am J Public Health 2008 May;98(5):853-61.

Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ. Patterns, Predictors, and Consequences of Initial Regimen Type among HIV-infected Women Initiating HAART. Clinical Infectious Diseases 2008 Jan 15;46:305-312.

Massad LS, Evans CT, Wilson TE, Golub ET, Goparaju L, Howard A, Greenblatt RM, Weber K, Schilder K. Impact of menopause on condom use by HIV seropositive and comparison seronegative women. JAIDS 2008;47(3):401-2.

Kapadia F, Vlahov D, Wu Y, Cohen M, Greenblatt R, Howard A, Cook J, Goparaju L, Golub ET, Richardson J, Wilson T. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse 2008;34(2):161-170.

pre-2008 Publications:

----------------------------------

Garfein RS, Golub ET, Greenberg A, Hagan H, Hanson DL, Hudson S, Kapadia F, Latka MH, Ouellet L, Purcell DW, Strathdee SA, Thiede H, for the DUIT Study Team. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS 2007;21(14):1923-1932.

Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka M, Hudson SM, Garfein RS. Distributive syringe sharing among young injection drug users in five U.S. cities. Drug and Alcohol Dependence 2007; 91 (Suppl 1):S30-S38.

Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Cashin L, Moxly MD, Weber KM, Watts DH. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis. 2007 Oct;11(4):240-250.

Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson D, Latka M, for the DUIT Study Team. Methods to recruit and retain a cohort of young adult injection drug users for the third Collaborative Injection Drug Users’ Study/ Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend 2007; 91(Suppl 1):S4-S17.

Coady MH, Latka MH, Thiede H, Golub ET, Ouellet L, Hudson SM, Kapadia F, Garfein RS. Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav 2007;11(6):854-63.

Purcell DW, Garfein RS, Latka MH, Thiede H, Hudson S, Bonner S, Golub ET, Ouellet L for the DUIT Study team. Development, Description, and Acceptability of a Small-Group, Behavioral Intervention to Prevent HIV and Hepatitis C Virus Infections among Young Adult Injection Drug Users. Drug Alcohol Depend 2007;91(Suppl 1):S73-S80.

Bailey SL, Ouellet L, Mackesy-Amiti ME, Golub ET, Hagan H, Hudson SM, Latka M, Thiede H, Gao W, Garfein RS for the DUIT Study Team. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young injection drug users in 5 U.S. cities: The CIDUS III/DUIT Study experience. Drug and Alcohol Dependence 2007; 91(Suppl 1):S18-S29.

Seifer DB, Golub ET, Lambert-Messerlian G, Springer G, Holman S, Moxley M, Cejtin H, Nathwani N, Anastos K, Minkoff H, Greenblatt RM. Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertility and Sterility 2007 Apr 4 [epub ahead of print].

Kapadia F, Latka M, Hudson SM, Golub ET, Campbell JV, Bailey S, Garfein RS. Correlates of consistent condom use with main partners by partnership patterns among male injection drug users from 5 US cities. Drug and Alcohol Dependence 2007;91(Suppl 1):S56-S63.

Campbell JV, Garfein RS, Thiede H, Hagan H, Ouellet LJ, Golub ET, Hudson SM, Ompad DC, Weinbaum C: for the DUIT Study Team. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend 2007;91(Suppl 1):S64-S72.

Massad LS, Evans CT, Wilson TE, Golub ET, Sanchez-Keeland L, Minkoff H, Weber K, Watts H. Contraceptive use among U.S. women with HIV. J Women’s Health 2007 Jun;16(5):657-66.

Morris JD, Golub ET, Mehta SH, Jacobson LP, Gange SJ. Injection Drug Use and Patterns of Highly Active Antiretroviral Therapy Use: An analysis of ALIVE, WIHS, and MACS cohorts. AIDS Research and Therapy 2007 June 6; 4:12.

Sharma A, Feldman JG, Golub ET, Schmidt J, Silver S, Robison E, Minkoff H. Live birth patterns among HIV-infected women before and after the availability of highly active antiretroviral therapy. Am J Obstet Gynecol 2007 Jun;196(6):541.e1-6.

Cook JA, Grey DD, Burke-Miller JK, Cohen MH, Vlahov D, Kapadia F, Wilson TE, Cook R, Schwartz R, Golub ET, Anastos K, Ponath C, Goparaju L, Levine A. Illicit drug use, depression, and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence, 2007 Jun 15; 89(1):74-81.

Massad LS, Evans C, Weber K, Cejtin HE, Golub ET, DiGilio K, Alpern A, Watts DH. Hysterectomy among women with HIV: Indications and incidence. J Acquir Immune Defic Syndr 2007 Apr 15;44(5):566-8.

Wisneiwski AB, Brown TT, John M, Frankowicz JK, Cofrancesco J, Golub ET, Ricketts EP, Dobs AS. Hypothalamic-pituitary-gonadal function in men and women using heroin and cocaine, stratified by HIV status. Gender Medicine 2007;4(1):35-44.

Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health care access among hepatitis C virus (HCV) positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health 2007 Jan;84(1):99-115.

Massad LS, Evans CT, Minkoff H, Watts DH, Greenblatt RM, Levine AM, Anastos K, Young M, Seifer DB, Golub ET, Cohen M. Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Women’s Health 2006;15(5):591-598.

Hagan H, Latka M, Campbell J, Golub ET, Garfein RS, Thomas DL, Kapadia F, Strathdee SA. Eligibility for treatment of hepatitis C virus infection among young injection drug users in three US cities. Clin Infect Dis 2006 Mar 1;42(5):669-72.

Campbell JV, Hagan H, Latka M, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 2006; 81:259-265.

Wisniewski AB, Brown TT, John M, Cofrancesco J Jr, Golub ET, Ricketts EP, Wand G, Dobs AS. Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology 2006 Feb;31(2):250-5.

Golub ET, Bareta JC, Mehta SH, McCall LD, Vlahov D, Strathdee SA. Correlates of safe syringe acquisition and disposal among injection drug users in Baltimore, MD. Substance Use and Misuse 2005;40(12):1751-64.

Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, Strathdee SA. Changes in willingness to participate in HIV vaccine trials among injection drug users. AIDS Behav 2005;9(3):301-309.

Strathdee SA, Latka M, Campbell J, O’Driscoll PT, Golub ET, Kapadia F, Pollini RA, Garfein RS, Thomas DL, Hagan H. for the STRIVE Project. Factors associated with interest in initiating Hepatitis C virus therapy among young HCV-infected drug users. Clin Infect Dis 2005 Apr 15;40 Suppl 5:S304-12.

Golub ET, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS, Thomas DL, Strathdee SA for the STRIVE Project. Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health 2004 June; 81(2): 278-290.

Sherman SG, Rusch M, Golub ET. Correlates of safe syringe acquisition and disposal practices among young IDUs: Broadening our notion of risk. Journal of Drug Issues 2004; 34(4):895-912.

Golub ET, Astemborski JA, Hoover DR, Anthony JC, Vlahov D, Strathdee SA. Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr 2003 Apr 1;32(4):429-34.

Golub ET, Strathdee SA. Editorial comment: Syringe access versus syringe disposal: the law of diminishing returns? The AIDS Reader 2002; 12(12):530-531.